{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:25:08Z","timestamp":1794201908947,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jhep.2021.04.013","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T17:41:07Z","timestamp":1618940467000},"page":"524-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-408X","authenticated-orcid":false,"given":"Geraldine J.","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-4665","authenticated-orcid":false,"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Earnest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-7997","authenticated-orcid":false,"given":"Stuart K.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-7273","authenticated-orcid":false,"given":"William","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-4188","authenticated-orcid":false,"given":"Matthew J.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.04.013_bib1","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.013_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.numecd.2019.08.001","article-title":"Insulin resistance, but not insulin response, during oral glucose tolerance test is associated to worse histological outcome in obese NAFLD","volume":"30","author":"Coccia","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2021.04.013_bib3","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/gutjnl-2016-312238","article-title":"Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity","volume":"66","author":"Bedossa","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.04.013_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.013_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cgh.2017.05.029","article-title":"Long-term outcomes of nonalcoholic fatty liver disease: from nonalcoholic steatohepatitis to nonalcoholic steatofibrosis","volume":"15","author":"Younossi","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.013_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2021.04.013_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo","volume":"34","author":"Williams","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jhep.2021.04.013_bib9","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jhep.2021.04.013_bib11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2021.04.013_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.013_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/liv.12685","article-title":"Characteristics of hepatic fatty acid composition in patients with nonalcoholic steatohepatitis","volume":"35","author":"Yamada","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.013_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2014.11.002","article-title":"Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity","volume":"62","author":"Anjani","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.013_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides-Lipotoxic induces metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2021.04.013_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"Van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R600011-JLR200","article-title":"Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity","volume":"47","author":"Koutsari","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2021.04.013_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jhep.2021.04.013_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the AASLD","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/obr.12628","article-title":"Systematic review and meta-analysis: non-invasive detection of NAFLD-related fibrosis in the obese","volume":"19","author":"Ooi","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.jhep.2021.04.013_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2021.04.013_bib23","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the AGA, AASLD, and ACG","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.013_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhep.2021.04.013_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib26","first-page":"1388","article-title":"Clinical practice guidelines for the management of NAFLD","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.013_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.013_bib28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/oby.21448","article-title":"Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans","volume":"24","author":"Tonks","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.jhep.2021.04.013_bib29","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1194\/jlr.P035808","article-title":"Plasma lipid profiling in a large population-based cohort","volume":"54","author":"Weir","year":"2013","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2021.04.013_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhep.2021.04.013_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jhep.2021.04.013_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/157016111705190703102816","article-title":"What does the future hold for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis?","volume":"17","author":"Doumas","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jhep.2021.04.013_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-019-0984-y","article-title":"An integrative systems genetic analysis of mammalian lipid metabolism","volume":"567","author":"Parker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.04.013_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.013_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.013_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2021.04.013_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2021.04.013_bib38","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/ATVBAHA.109.191585","article-title":"Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration","volume":"29","author":"Tan","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2021.04.013_bib39","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3390\/molecules20022425","article-title":"A\u00a0review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (c15:0) and heptadecanoic acid (c17:0) in health and disease","volume":"20","author":"Jenkins","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jhep.2021.04.013_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.1961","article-title":"Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis","volume":"12","author":"Green","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jhep.2021.04.013_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2021.04.013_bib42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS60 dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2021.04.013_bib43","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.12331","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease","volume":"34","author":"Kurek","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.013_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2021.04.013_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2021.04.013_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2337\/db12-0686","article-title":"Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance","volume":"62","author":"Boon","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2021.04.013_bib47","series-title":"CERAM-MI-Heart ceramide, plasma","author":"Test","year":"2020"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T08:55:26Z","timestamp":1736585726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0168827821002488"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.04.013","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}